QUT scientists have discovered a promising new therapy for a deadly type of endometrial cancer that has a poor prognosis if the cancer spreads or returns after initial treatment, a plight that affects 15-20 per cent of endometrial cancer patients.
Low-dose aspirin does not affect the progression of age-related hearing loss
The effect of daily low-dose aspirin versus placebo on the progression of age-related hearing loss in healthy older adults.